Review



etoh  (Decon Laboratories)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Decon Laboratories etoh
    Etoh, supplied by Decon Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/etoh/product/Decon Laboratories
    Average 86 stars, based on 1 article reviews
    etoh - by Bioz Stars, 2026-05
    86/100 stars

    Images



    Similar Products

    u0126 etoh  (MedChemExpress)
    94
    MedChemExpress u0126 etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    U0126 Etoh, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/u0126 etoh/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    u0126 etoh - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    etoh  (Biotium)
    96
    Biotium etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Etoh, supplied by Biotium, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/etoh/product/Biotium
    Average 96 stars, based on 1 article reviews
    etoh - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    anhydrous ethanol etoh  (Servicebio Inc)
    86
    Servicebio Inc anhydrous ethanol etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Anhydrous Ethanol Etoh, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anhydrous ethanol etoh/product/Servicebio Inc
    Average 86 stars, based on 1 article reviews
    anhydrous ethanol etoh - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    nh3h2o etoh  (Daicel Corporation)
    86
    Daicel Corporation nh3h2o etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Nh3h2o Etoh, supplied by Daicel Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nh3h2o etoh/product/Daicel Corporation
    Average 86 stars, based on 1 article reviews
    nh3h2o etoh - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ethanol etoh  (Fisher Bioreagents)
    86
    Fisher Bioreagents ethanol etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Ethanol Etoh, supplied by Fisher Bioreagents, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ethanol etoh/product/Fisher Bioreagents
    Average 86 stars, based on 1 article reviews
    ethanol etoh - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ethanol etoh  (Carlo Erba Reagents)
    86
    Carlo Erba Reagents ethanol etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Ethanol Etoh, supplied by Carlo Erba Reagents, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ethanol etoh/product/Carlo Erba Reagents
    Average 86 stars, based on 1 article reviews
    ethanol etoh - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    etoh  (Decon Laboratories)
    86
    Decon Laboratories etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Etoh, supplied by Decon Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/etoh/product/Decon Laboratories
    Average 86 stars, based on 1 article reviews
    etoh - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    etoh  (Shanghai Yuanye Biochemicals)
    86
    Shanghai Yuanye Biochemicals etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Etoh, supplied by Shanghai Yuanye Biochemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/etoh/product/Shanghai Yuanye Biochemicals
    Average 86 stars, based on 1 article reviews
    etoh - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    etoh  (Fisher Scientific)
    86
    Fisher Scientific etoh
    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 <t>(U0126-EtOH,</t> 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
    Etoh, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/etoh/product/Fisher Scientific
    Average 86 stars, based on 1 article reviews
    etoh - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 (U0126-EtOH, 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.

    Journal: iScience

    Article Title: Targeting USP14 enhances immunotherapy response by reprogramming tumor-associated macrophages in colon cancer

    doi: 10.1016/j.isci.2026.115362

    Figure Lengend Snippet: Identification of the mechanism underlying IU1-mediated reprogramming of M2 macrophages (A and B) Verification of the efficiency of i.v. injection of clodronate liposome (Clo) in depleting TAMs of the blood (A) and the TME (B). (C and D) Statistics of tumor size monitored for 21 days in MC38 tumor-bearing mice after various indicated treatments. (E) Statistic of the percentage of CTLs in the TME after the indicated treatment. (F) Volcano plots of the differentially expressed genes between the PBS and the IU1 group. Red dots show significantly up-regulated genes in the IU1 group, and green dots show significantly down-regulated genes. (G) Heatmap illustrates the differentially expressed M1-and M2-related genes in TAMs in the IU1 group and the PBS group based on RNA sequencing results. (H) KEGG analysis identifies the 17 most enriched pathways based on the differentially expressed genes of the two groups. (I) Western blotting of p -JNK, p -ERK, p-p38, and GAPDH in IL-4/13-BMDM M2 cells treated with IU1 at the indicated time points. (J) RT-PCR to verify the typical M1/M2 polarization-related genes in M2 macrophages after treatment with IU1. (K) Flow cytometry analysis of CD206 expression on the IL-4/13-induced BMDM M2 cells from various indicated treatments. Treatments indicated: DMSO stimulation, IU1 (10 μM) stimulation, IU1 (10 μM) stimulation in the presence of inhibitors of p38 (SB203580, 10 μM), JNK (SP600125, 10 μM), Erk1/2 (U0126-EtOH, 10 μM). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.

    Article Snippet: U0126-EtOH , MedChemExpress , HY-12031.

    Techniques: Injection, RNA Sequencing, Western Blot, Reverse Transcription Polymerase Chain Reaction, Flow Cytometry, Expressing, Comparison